L-Tryptophan 500 mg - 120 Vcaps®
Item#: 0167
Manufacturer SKU: 733739001672
- Pharmaceutical Grade
- Encourages Positive Mood
- Promotes Restful Sleep*
- Vegetarian Formula
L-Tryptophan is an essential amino acid important in human nutrition for the synthesis of melatonin and serotonin, hormones regulating mood and synthesis of melatonin and serotonin, hormones regulating mood and stress response. L-Tryptophan helps support relaxation, sleep, positive mood and immune function.* As an essential amino acid, it is not synthesized by the body and must be obtained from the diet. NOW® L-Tryptophan is pharmaceutically pure - every lot is tested to be free of Peak E and microbial contamination.
Suggested Usage
As a dietary supplement, take 1-2 Vcaps® 2 to 3 times daily on an empty stomach or as directed by a health care professional. Best used at bedtime.
Consider taking these other NOW® products:| Serving Size: | 2 Vcaps® | ||
|---|---|---|---|
| Servings Per Container: | 60 | ||
| Amount Per Serving | % Daily Value* | ||
|
* Percent Daily Values are based on 2,000 calorie diet. † Daily Value not established. |
|||
| L-Tryptophan (Free-Form) | 1.0 g (1,000 mg) | † | |
Other Ingredients: Cellulose (capsule), Cellulose and Stearic Acid (vegetable source).
Contains no: sugar, salt, yeast, wheat, gluten, soy, milk, egg, shellfish or preservatives.
Vegetarian/Vegan Product.
Warning: Keep out of reach of children. Pregnant/lactating women, those taking anti-depressant medications (such as SRRI's or MAOI's), or those with liver disorders, consult a health care professional before using this product. May cause drowsiness.
Caution: Do Not Eat Freshness Packet. Keep in Bottle.
NOW® L-Tryptophan is Pharmaceutical Grade.
Vcaps® is a registered trademark of Capsugel.
Store in a cool, dry place. Please Recycle.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This information current as of 6/15/12 3:16 PM.


Vitamin B Pure Powders




E-Newsletter sign-up
Facebook
Twitter